Jabbour EJ, Short NJ, Jain N, Jammal N, et al. Blinatumomab Is Associated with Favorable Outcomes in Patients With B-cell Lineage Acute Lymphoblastic Leukemia and Positive Measurable Residual Disease at a Threshold of 10(-4) and Higher. Am J Hematol 2022 Jun 17. doi: 10.1002/ajh.26634.
PMID: 35713551